Trial Profile
Virologic and Immunologic Responses in Treatment-Naive Patients to Ritonavir-Boosted Atazanavir or Efavirenz With a Common Backbone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Atazanavir/ritonavir (Primary) ; Efavirenz (Primary) ; Emtricitabine; Lamivudine; Tenofovir
- Indications HIV infections
- Focus Therapeutic Use
- 21 Dec 2015 New trial record